Document is current
Any future updates will be listed below
-
Authors
Matta, Sarah
Lamard, Mathieu
Conze, Pierre-Henri
Le Guilcher, Alexandre
Lecat, Clément
Carette, Romuald
Basset, Fabien
Massin, Pascale
Rottier, Jean-Bernard
Cochener, Béatrice
Quellec, Gwenolé
- License Information
-
More Information
Article History
Received: 21 June 2022
Accepted: 11 July 2023
First Online: 17 July 2023
Competing interests
: The authors Sarah Matta, Mathieu Lamard, Pierre-Henri Conze and Jean-Bernard Rottier declare no Competing Financial or Non-Financial Interests. The authors Clément Lecat, Fabien Basset and Romuald Carette declare no Competing Non-Financial Interests but the following Competing Financial Interests: Employee – Evolucare Technologies. The author Alexandre Le Guilcher declares no Competing Non-Financial Interests but the following Competing Financial Interests: Research & Innovation director – Evolucare Technologies; CEO – OphtAI. The author Pascale Massin declares no Competing Non-Financial Interests but the following Competing Financial Interests: Consultant – Allerga, Bayer, Novartis, Thea, Horus. The author Béatrice Cochener declares no Competing Non-Financial Interests but the following Competing Financial Interests: Consultant and clinical investigator – Thea, Alcon, Zeiss, B&L, Hoya, Horus, Santen, SIFI, Cutting Edge, J&J. The author Gwenolé Quellec declares no Competing Non-Financial Interests but the following Competing Financial Interests: Consultant – Evolucare Technologies, Adcis.
